About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
https://soho2018.org/
Session I: Chronic Myeloid Leukemia
Session II: Myelodysplastic Syndromes
Session III: Myeloproliferative Neoplasms
Session IV: Acute Lymphoblastic Leukemia
Session V: Acute Myeloid Leukemia
Plenary Sessions
Breakfast with the Expert
Session VI: Multiple Myeloma
Program of Events
Session VIII: Non-Hodgkin Lymphoma
Session IX: Chronic Lymphocytic Leukemia
Session X: Research Topics
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
T
Oral Abstract MDS 304: Mutational Landscape of Therapy-Related Myeloid Neoplasms
By
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
FEATURING
Teodora Kuzmanovic
By
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
FEATURING
Teodora Kuzmanovic
8 views
November 5, 2018
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Session II: Myelodysplastic Syndromes
12:31
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Selecting the Right Low-Risk MDS Patient For Allogeneic Hematopoieti…
Feat.
U. Platzbecker
16:07
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
What is New In MDS in 2018?
Feat.
V. Santini
11:10
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Inherited Predisposition and Pediatric MDS
Feat.
M. Wlodarski
15:59
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
DEBATE: Should MDS Diagnosis Still Be Mainly Based on Morphology? Yes
Feat.
R. Hasserjian
20:14
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
DEBATE: Should MDS Diagnosis Still Be Mainly Based on Morphology? No
Feat.
L. Godley
15:20
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Improving MDS Results of Hypomethylating Agents (HMAs): Current Situ…
Feat.
P. Fenaux
09:09
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Oral Abstract MDS 161: Distinct Genomic Associations to Predict Acut…
Feat.
Y. Madanat
09:28
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Oral Abstract MDS 304: Mutational Landscape of Therapy-Related Myelo…
Feat.
T. Kuzmanovic
15:35
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Problems Ahead in MDS: What Is Next?
Feat.
G. Garcia-Manero
